Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT07051980

Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study

Led by Zhejiang University · Updated on 2025-07-17

50

Participants Needed

1

Research Sites

81 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Endoscopic retrograde cholangiopancreatography (ERCP) is a technique for evaluating the bile duct, pancreatic duct, and ampulla. Hypoxia is the most common cardiopulmonary complication during ERCP, with a reported rate of 16.2 to 39.2%. The key to preventing hypoxia is to ensure the sufficient oxygenation and ventilation of patients during these procedures. The commonly used approaches to treat hypoxia with a non-instrumented airway are increasing the oxygen flow and lifting the jaw, applying with both hands, displacing the jaw upwards and anteriorly, which allowed the upper airway to remain open. We hypothesized that the supraglottic oxygen delivery via an endotracheal tube can reduce the incidence of hypoxia in patients under deep sedation during ERCP.

CONDITIONS

Official Title

Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • ASA classification between I and III
  • Signed informed consent form
  • Scheduled for sedated ERCP examination
  • Estimated procedure duration not exceeding 45 minutes
Not Eligible

You will not qualify if you...

  • Severe cardiac dysfunction (less than 4 METs)
  • Severe renal insufficiency requiring preoperative dialysis
  • Diagnosed chronic obstructive pulmonary disease or other acute/chronic pulmonary diseases needing ongoing oxygen therapy
  • Increased intracranial pressure
  • Upper respiratory tract infections (oral, nasal, or pharyngeal)
  • Fever with core temperature above 37.5°C
  • Confirmed pregnancy or currently breastfeeding
  • Allergy to sedatives like propofol or medical adhesives
  • Body mass index over 30 kg/m²
  • Current participation in other clinical trials

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

Research Team

D

DiSan Head of Anesthesiology, PhD

CONTACT

L

Lianjuan Sun, Master

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here